Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

922
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
922
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

746
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
746
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
International Nursing Organizations II01:28

International Nursing Organizations II

1.5K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging remnant viral load samples for SARS-CoV-2 antibody seroprevalence trends among PLHIV in Kenya, February 2021-October 2022: a cross-sectional surveillance survey.

BMJ public health·2026
Same author

Pediatric Health at the Crossroads of Climate Change, Food Insecurity, and Malnutrition.

Advances in nutrition (Bethesda, Md.)·2026
Same author

Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique.

Emerging infectious diseases·2026
Same author

Funnel-based antimicrobial resistance monitoring in Italy: the FUN-IT study.

Scientific reports·2025
Same author

Specialist Healthcare Intervention and Follow-up Trends in Post-Acute COVID-19 Hospitalization as Compared to Other Respiratory Infections.

Infectious diseases and therapy·2025
Same author

Synergising one health and environmental, social, and governance (ESG) standards: A scoping review.

One health (Amsterdam, Netherlands)·2025

Related Experiment Video

Updated: Apr 14, 2026

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Global Tuberculosis Control: Toward the 2015 Targets and Beyond.

Emilio Dirlikov, Mario Raviglione, Fabio Scano

    Annals of Internal Medicine
    |April 28, 2015
    PubMed
    Summary

    Global tuberculosis (TB) control efforts face significant challenges, including drug resistance and HIV co-infection. Future strategies must integrate innovations and social protection for effective prevention and treatment.

    Area of Science:

    • Public Health
    • Infectious Diseases
    • Global Health

    Background:

    • Tuberculosis (TB) remains a critical global health threat, despite progress since 1990.
    • In 2013, TB caused an estimated 9.0 million new cases and 1.5 million deaths worldwide.
    • Co-infection with HIV and multidrug-resistant TB (MDR-TB) complicate control efforts.

    Purpose of the Study:

    • To review the global TB control landscape beyond 2015.
    • To identify challenges and propose strategies for future TB control.
    • To emphasize TB control as a public health and economic development priority.

    Main Methods:

    • This abstract is a review and does not detail specific experimental methods.
    • It synthesizes global TB statistics and identifies key challenges.

    More Related Videos

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
    10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    19.4K
    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
    06:26

    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

    Published on: July 28, 2023

    3.3K

    Related Experiment Videos

    Last Updated: Apr 14, 2026

    Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
    06:07

    Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

    Published on: June 6, 2025

    1.5K
    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
    10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    19.4K
    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
    06:26

    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

    Published on: July 28, 2023

    3.3K
  • It discusses the need for integrated control strategies.

    • Main Results:

    • Despite progress, TB remains a major global health issue with millions of cases and deaths annually.
    • Multidrug-resistant TB and HIV co-infection present substantial challenges.
    • Adverse socioeconomic factors and noncommunicable diseases also impact TB control.

    Conclusions:

    • Future TB control requires technical and operational innovations.
    • Universal health coverage and social protection are crucial for access to prevention, diagnostics, and treatment.
    • Integrating TB control into economic development plans is essential.